News analysis

China to approve foreign-made mRNA vaccine soon

China's drug regulator is set to give the green light for the first foreign-made mRNA vaccine.

Shanghai-based Fosun Pharma said the National Medical Products Administration (NMPA) recently completed an expert panel review of an mRNA Covid-19 vaccine co-developed by the company and German firm BioNTech.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

A version of this article appeared in the print edition of The Straits Times on July 22, 2021, with the headline 'China to approve foreign-made mRNA vaccine soon'. Subscribe